Resistance case definition
Frame the pathogen, resistance mechanism, anchor antibiotic, and validation goal before any ranking begins.
Output: AMR case profileAI platform for AMR drug repurposing
From resistant pathogens to wet-lab-ready AMR dossiers.
Bactrix helps pharma, biotech, and research teams find overlooked antibiotic-rescue opportunities, rank them with transparent AI, and turn the best leads into clear validation dossiers.
AI evidence mining. Clear scoring. Practical lab next steps.
Urgent gapAMR is moving faster than traditional discovery cycles.
AI rankingPrioritizes non-obvious combinations from fragmented evidence.
Lab-readyPackages assay logic for MIC, synergy, and mechanism validation.
Partner-readyCreates diligence-ready outputs for teams deciding what to test next.
Services
The fastest path from AMR problem to testable combination.
AMR teams do not need another black-box prediction or a generic compound dump. They need ranked, defensible starting points that make scarce wet-lab capacity count.
Define the pathogen, resistance profile, and antibiotic to rescue.
Rank promising approved-drug adjuncts with visible score logic.
Export a concise dossier for lab and partner review.
Unexplored combo discovery
Surface approved or known molecules that may help restore antibiotic activity and deserve focused testing.
Output: ranked candidate matrixEvidence and docking layer
Show the evidence basis, safety context, and confidence level so the result is reviewable rather than black-box.
Output: review-ready evidence packWet-lab-ready dossier
Deliver the shortlist, rationale, risk flags, and next validation step in a clear scientific review export.
Output: PDF, CSV, or lab dossierWhy Us
We turn a massive AMR search space into expert-verified rescue opportunities.
Bactrix is built to test more evidence, surface overlooked drug combinations, and deliver wet-lab-ready dossiers that can survive scientific and commercial scrutiny.
Scale
We search across a larger evidence surface
Bactrix evaluates pathogen context, resistance mechanisms, literature signals, chemistry, safety, and drug data at a scale manual screening cannot match.
Discovery
We repurpose unexplored combinations
The platform looks beyond obvious antibiotics and known pairings to identify under-tested drug combinations that may help restore activity against resistant bacteria.
AI
We use modern AI for prioritization
Latest AI workflows mine fragmented AMR evidence, rank candidates by resistance-aware fit, and convert the output into clear dossiers instead of raw prediction dumps.
Validation
Experts verify what the platform finds
Results are reviewed manually and strengthened with input from expert scientists and renowned pharma consultants around the world before partner handoff.
Case Study
Omeprazole case study: from resistance signal to combination validation plan.
A focused N. gonorrhoeae rescue model showing how Bactrix evaluates omeprazole with ceftriaxone and edetic acid/EDTA as a testable adjunct-therapy hypothesis.
01
Omeprazole + ceftriaxone rescue hypothesis
The case frames omeprazole as a repurposed adjunct candidate for ceftriaxone rescue in resistant N. gonorrhoeae biology.
02
Combination context with EDTA
The dossier separates direct-target claims from indirect potentiation, permeability, and compatibility questions around the combination.
03
Wet-lab validation package
The output converts the hypothesis into checkerboard MIC, FIC index, time-kill, cytotoxicity, and compatibility tests.
Partner Access
Private access for pharma, biotech, and validation partners.
Bactrix is opening controlled review sessions for teams that want to evaluate AI-ranked AMR rescue dossiers and wet-lab partnership opportunities.
For pharma teams searching for overlooked antibiotic-rescue combinations
For labs that can validate prioritized AMR candidates
For strategy teams evaluating the platform, evidence model, and partnership path
Enter partner access code
Launch the private Bactrix console for approved diligence and partner sessions.
Invalid access code. Contact the team for access.
Need diligence access or partnership review? Email hello@bactrix.com